The Fetal Medicine Foundation 20th World Congress in Fetal Medicine, Valencia, Spain
Abstracts
 
  • Aneuploidies
  • cfDNA test
  • Defects
    • Brain
    • Face
    • Heart
    • Lungs
    • Gastrointestinal
    • Abdominal wall
    • Genitourinary
    • Spine
    • Skeleton
    • Hydrops
    • Placenta
    • Other
  • Genetics
    • Exome sequencing
    • Other
  • Artificial placenta
  • Fetal therapy
  • Fetal anemia
  • Congenital infection
    • CMV
    • COVID 19
    • Other
  • Maternal medicine
  • Preeclampsia
  • Gestational diabetes
  • Growth
  • Preterm birth
  • Obstetrics
  • Twins
    • TTTS
    • sFGR
    • TRAP
    • Other
  • Miscellaneous

Fetal anemia

  1. Fetal blood group screening: an audit at Guy’s and St. Thomas’ Hospital, London View pdf
  2. Hemolytic disease of the fetus and newborn: safety, efficacy, and outcomes View pdf
  3. Nipocalimab in pregnancies at risk for severe memolytic disease of the fetus and newborn View pdf
  4. Pregnancies at risk of developing hemolytic disease of the fetus and newborn View pdf
  5. Rhesus mediated hemolytic disease of the fetus and newborn View pdf
  6. Safety and efficacy of Nipocalimab in early-onset severe hemolytic disease of the fetus and newborn (HDFN) View pdf
  7. The clinical characteristics of severe early-onset hemolitic disease of fetus and newborn View pdf
  8. The economic burden of haemolytic disease of the fetus and newborn: a systematic literature review View pdf
  9. The effect of intrauterine transfusions for hemolytic disease of the fetus and newborn View pdf
483245074506464348354503475945464839
© 2023 The Fetal Medicine Foundation